CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...
Abstract: Fault diagnosis and remaining useful life (RUL) prediction technologies are critical for aircraft hydraulic systems to ensure flight safety and optimize maintenance schedules. This article ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈